Microbiology
============

*Streptococcus pyogenes* IL-8 protease is inhibited by pheromone
----------------------------------------------------------------

The strictly human pathogen *Streptococcus pyogenes* causes relatively mild localized upper respiratory tract and skin infections, but occasionally causes severe invasive and/or tissue-destroying infections with high mortality. *S. pyogenes* has evolved several strategies to evade the immune response by binding to plasma proteins and immune regulators, as well as immuno-modulating enzymes interacting with the immune system [@BIB1].

Hidalgo-Grass *et al*. [@BIB2] analyzed *S. pyogenes* isolates and tissues from patients with necrotizing infections. Infected tissue contained numerous bacteria, but no infiltrating neutrophils. Bacteria were shown to release a protease activity that degrades the human chemokine interleukin 8 (IL-8), which is important for neutrophil recruitment. In a mouse model of soft-tissue infection the bacteria produced fatal necrotic infections with reduced neutrophil infiltration. Furthermore, the strains were mutated in *silCR*, encoding the pheromone peptide SilCR. Purified SilCR inhibited production of IL-8 protease activity *in vitro* and restored neutrophil migration, thereby rescuing mice infected with original isolates and well as heterologous strains.

This study describes a new immuno-modulating enzymatic activity (IL-8 protease) of *S. pyogenes*, but the exact nature of the enzyme is unclear and needs to be further addressed. Nevertheless, the study clearly demonstrates that peptide pheromones have therapeutic potential in serious necrotizing infections by regulating bacterial protein expression.

Genome plasticity in *Streptomyces*
-----------------------------------

*Streptomyces* bacteria are important organisms not only in the natural environment but also in the pharmaceutical and agricultural industries where their secondary metabolites are harvested and used for several different purposes. Studying the genomes of different *Streptomyces* strains will provide valuable insight and aid our understanding of these microbes at the molecular level, with the possibility of better genetic engineering of these organisms for beneficial purposes.

The central portion of the *Streptomyces coelicolor* 8.7 Mb linear genome encodes conserved housekeeping genes essential for growth, but the ends (or\'arms\') the genome are highly dynamic and vary greatly in structure and gene content. In a recent paper by Weaver *et al*. [@BIB3], the chromosomes of several laboratory derivatives of *S. coelicolor* strain A3(2) were found to have 1.06 Mb of inverted repeat sequences at their termini (so-called long-terminal inverted repeats or L-TIRs). This was in marked contrast to the sequenced *S. coelicolor* strain M145, which had TIRs only 22 kb in size and was thought to be genetically similar to the other derivatives containing L-TIRs.

As many of the *S. coelicolor* strains with short TIRs were exposed to ultraviolet (UV) or X-ray light during laboratory manipulation, the authors hypothesized that X-ray and/or UV irradiation could have induced truncation of the L-TIR to the 22 kb length, and they confirmed this experimentally. The L-TIRs are the longest terminal sequences so far reported for an actinomycete, and the authors have proposed that they represent the chromosomal structure of the original soil isolate of *S. coelicolor* A3(2).

Cancer
======

Loss of c-*Myc* confers selective resistance to apoptosis
---------------------------------------------------------

The nuclear proto-oncogene c-*Myc* plays and important role in proliferation, differentiation and apoptosis. Overexpression of c-*Myc* in the presence of survival factors leads to proliferation and to apoptosis in the absence of survival factors. Grassilli *et al.* now confirm the importance of c-*Myc* in apoptosis by showing that c-*Myc*-null cells are resistant to apoptosis by several anticancer agents [@BIB4]. Doxorubicin and etoposide-induced apoptosis is impaired in c-*Myc* null cells, whereas camptothecin-induced cell death occurs normally. The authors show that p53 and its proapoptotic effector molecule Bax accumulate in c-*Myc* null cells exposed to doxorubicin, but fail to die.

This important finding shows that c-*Myc* does not merely induce apoptosis by inducing p53, but that c-*Myc* itself is needed for final execution of death. This confirms the early studies of c-*Myc*-induced apoptosis in rat-1 fibroblasts, which are effectively killed by overexpression of c-*Myc* in absence of survival factors. The authors show that complete protection can from doxorubicin-induced apoptosis in wild-type cells can only be achieved when caspases, serine proteases and cytochrome *c* release are blocked simultaneously and suggest c-*Myc* is essential to all pathways.

Future research will be needed to see if these findings can be extrapolated to other oncogenes and determine whether loss of functions will confer resistance to certain subsets of anticancer drugs. The current data have implications for the clinical setting and could change the choice of drugs for treatment of tumors driven by a MYC family member.

Lessening the Resistance
------------------------

Tumor cells can develop a very effective resistance mechanism to multiple antitumoral drugs, causing the failure of cancer chemotherapy treatments. The multiple drug resistance (MDR) is due to either the cell-surface overexpression of transmembrane efflux pumps, P-glycoprotein (Pgp) or the constitutive expression of multidrug resistance-related proteins (MRPs) that are homologous to Pgp, and like Pgp are members of the ABC family. They transport a multitude of drugs outside of the cell and are not specific.

The most recent strategy in cancer treatment is the concomitant administration of antitumoral drugs with a MDR-modulator, which can cause tumor cell death. Therefore, many efforts are geared towards the synthesis and the study of MDR-modulators that specifically inhibit the transporter and allow the antitumor drug to stay inside the cell and provoke cell death.

Lee *et al*. [@BIB5] identified a series of dihydropyrroloquinolines derivatives that reverse Pgp-mediated MDR without antagonizing MRP. Among these derivatives, PGP-4008 was the most promising. PGP-4008 activity was characterized with different cell lines, and the authors showed that it potentiates the cytotoxicity of Pgp substrates only on cell lines that overexpress Pgp, and increases drug accumulation inside the cell. PGP-4008 has no effect on non-Pgp-overexpressing cells, nor does it affect the toxicity of non-Pgp substrates. PGP-4008 is specific to Pgp and does not antagonize MRP. *In vivo*, tumor growth was significantly slower when mice were treated with a combination of PGP-4008 and doxorubicin. Although more clinical studies are necessary to better characterize PGP-4008, it seems to be a promising drug because it specifically reverts Pgp-mediate MDR.

Virology
========

SARS: structures from components of the virus are beginning to emerge
---------------------------------------------------------------------

Severe acute respiratory syndrome (SARS) is a member of the coronavirus family. It has a complex genetic organisation and so the replication cycle is poorly understood. Family members have a large replicase gene that is processed into a number of components that form a replication/transcription complex. This complex includes nonstructural proteins (nsp) of unknown function. Egloff *et al*. [@BIB6] have solved the structure of one of these proteins, nsp9, and shown that it binds to single-stranded RNA (ssRNA).

Nsp9 is dimeric, with each monomer containing an β -helix and a barrel of 7 β-strands. The sequence has no known homologues, but the β -barrel is similar to the 5-stranded β -barrel of the oligosaccharide/oligonucleotide-binding (OB) fold, mainly found in nucleic acid-binding proteins. If nsp9 and the OB fold are superimposed the binding site would be within the dimer interface of nsp9, suggesting that nsp9 represents a new variant of the OB fold.

The authors showed that nsp9 does bind to ssRNA by examining tryprophan fluorescence quenching in the presence of ssRNA or ssDNA oligonucleotides. Nsp9 bound with a similar affinity to both RNA and DNA, probably via a negatively charged surface on the dimer, suggesting that it is not sequence specific.

A lot of work is now going into solving the structures of the proteins encoded by the SARS coronavirus genome to help develop antiviral drugs that could prevent future epidemics. Single-stranded nucleotide-binding proteins encoded by viruses are frequently essential, so nsp9 is potentially a good target.
